PHS
NEO icon

PFM Health Sciences’s NeoGenomics NEO Stock Holding History

PFM Health Sciences’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,784,552
Closed -$13.2M – 107
2026
Q1 		$13.2M Buy
1,784,552
+90,501
+5% +$952K 1.21% 26
2025
Q4 		$19.9M Sell
1,694,051
-514,479
-23% -$5.55M 1.99% 17
2025
Q3 		$17M Buy
2,208,530
+1,438,492
+187% +$10.1M 1.31% 23
2025
Q2 		$5.63M Buy
770,038
+184,657
+32% +$1.49M 0.48% 40
2025
Q1 		$5.56M Buy
+585,381
New +$7.31M 0.4% 42

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

PFM Health Sciences's NEO Position: Q2 2026 in Review

PFM Health Sciences sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 1,784,552 shares — an estimated $13.2M sold.

PFM Health Sciences first reported a position in NEO in Q1 2025 and held it in 5 quarters. The position peaked at $19.9M in Q4 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • PFM Health Sciences reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • PFM Health Sciences sold 1,784,552 NeoGenomics shares in Q2 2026, an estimated $13.2M.
  • PFM Health Sciences first reported a position in NeoGenomics in Q1 2025 and held it in 5 quarters.
  • PFM Health Sciences's NeoGenomics position peaked at $19.9M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.